Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Common-Stock" stands at 591.40 Million United States Dollars as of 09/30/2025, the lowest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Common Stock" stands at 591.40 Million USD. This represents a decrease of -0.1 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.4209 percent compared to the value the year prior.
The 1 year change in percent is -0.4209.
The 3 year change in percent is -0.4545.
The 5 year change in percent is -1.12.
The 10 year change in percent is -14.66.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Common Stock | 486,508,953,600.00 |
![]() | AbbVie Inc - Common Stock | 399,570,305,024.00 |
![]() | Roche Holding AG - Common Stock | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Common Stock | 280,205,508,085.11 |
![]() | Novartis AG - Common Stock | 255,096,620,580.91 |